about
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials.Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancerGrowing indication for FNA to study and analyze tumor heterogeneity at metastatic sites.Metastatic breast cancer: mechanisms and opportunities for cytology.Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling.Intratumor Heterogeneity in Breast Cancer.Genotypes and prevalence of HPV single and multiple concurrent infections in women with HSIL.Primary relapse site pattern in women with triple-negative breast cancer.p-mTOR expression is associated with better prognosis in luminal breast carcinoma.Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.MicroRNA signatures in cytopathology: Are they ready for prime time?Androgen receptor expression in normal breast tissue and subsequent breast cancer riskSPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.Training does not affect exhaled nitric oxide in competitive swimmersTumor heterogeneity: the Lernaean hydra of oncology?Whole-Exome Analysis of Metaplastic Breast Carcinomas with Extensive Osseous DifferentiationPrimary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesisOutcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based studyWhole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breastPredicting breast tumor proliferation from whole-slide images: The TUPAC16 challengeAncillary Tests in Breast Cytology: A Practical GuideEN1 Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain Metastasis
P50
Q35538100-133B5EE2-4E66-4358-9E58-20F555C21F28Q36214202-5EFDEEDB-B6AB-4049-B0E7-F82CCC8484BBQ37396926-13DE7167-BD56-44F1-B5BC-963D7D8B809BQ37678666-49BBDA61-AFF7-436C-8C83-80AF65EDBD48Q37696072-BAE552A7-4F48-4A80-8110-B02B160CD23AQ38183348-C60A55AC-CC42-49FB-8E36-3C06DC44A26FQ38216999-06A0669B-2531-462D-AF8D-2F5BA96E2911Q38726739-40E4BD8C-4BFE-4B01-89F3-B5792487E95CQ38778540-2104671A-E703-491C-A55C-E2AF70A64FD9Q42231866-527AA09E-B951-46B6-B441-979463BD89B0Q42460808-26613722-E39F-4ADD-877E-5A4CA8EB8AF7Q43595352-E9E96828-1AAB-4FDD-BC8D-9036327D48C2Q46124450-E2AF9629-FCE6-4C0C-854D-E83344FB898BQ47956436-65B38240-C1A3-4092-BE93-45DFD3175F83Q47984396-2649A986-CCF5-4D02-96F6-049E77E25E9AQ53105514-5571D119-EDAF-49D0-90D3-BAD47D8D1CE5Q57071354-37EC171D-D184-4B2E-A045-6F65F3639286Q64947175-10098242-1003-4E13-93E4-C2C58CEDC187Q81033039-E3D92A33-7672-4188-9F7C-9AFFEA42A222Q85316820-15A20A83-792E-450A-86F1-883DA99B5634Q89645676-1B324E1C-8FC5-4C76-964C-C12B89253209Q89983786-A99DD300-5C17-4A8C-B915-3E463C1C8570Q92214050-CCDFEC10-155C-45C8-A7D3-3BDFCAADE6FDQ92287359-1C3974CC-5586-408D-ACB4-A9ABC950E711Q92302594-F5D7A596-5B66-4A45-BE20-2550D5681347Q92375817-875CAAE3-76CD-4DF4-8C13-A8907F39B39AQ93022796-426C43E9-7EE1-4CB3-9AA4-959DA7681A73
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Francisco Beca
@ast
Francisco Beca
@en
Francisco Beca
@es
Francisco Beca
@nl
Francisco Beca
@sl
type
label
Francisco Beca
@ast
Francisco Beca
@en
Francisco Beca
@es
Francisco Beca
@nl
Francisco Beca
@sl
altLabel
de Beca FF
@en
prefLabel
Francisco Beca
@ast
Francisco Beca
@en
Francisco Beca
@es
Francisco Beca
@nl
Francisco Beca
@sl
P108
P106
P108
P1153
55615769100
P21
P31
P3835
francisco-beca
P496
0000-0002-4409-012X